In vivo studies using B16 melanoma cells injected into nude mice showed that CCR7-expressing melanoma cells migrated more efficiently to lymphatic tissue in response to CCL21 that could be inhibited by a CCL21 neutralizing antibody [225]. Here, CCR7 is linked to melanoma.